Tumour angiogenesis and repulsive guidance molecule b: A role in HGF- and BMP-7-mediated angiogenesis

Sanders,Andrew  J.; Ye,Lin; Li,Jin; Mason,Malcolm  D.; Jiang,Wen  G.

doi:10.3892/ijo.2014.2508

Tumour angiogenesis and repulsive guidance molecule b: A role in HGF- and BMP-7-mediated angiogenesis

Authors:
- Andrew J. Sanders
- Lin Ye
- Jin Li
- Malcolm D. Mason
- Wen G. Jiang
View Affiliations

Affiliations: Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Cardiff, UK, Section of Oncology and Palliative Medicine, Cardiff University School of Medicine, Cardiff, UK
Published online on: June 20, 2014 https://doi.org/10.3892/ijo.2014.2508
Pages: 1304-1312

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocyte growth factor (HGF) is a key growth factor linked to promoting cancer progression and angiogenesis. The present study identifies repulsive guidance molecule b (RGMb), a bone morphogenetic protein (BMP) co-receptor, as a gene whose expression is regulated by HGF and explores the potential of RGMb to contribute to the process of angiogenesis. Microarray analysis was used to identify HGF responsive genes in HECV endothelial cells, identifying RGMb. RGMb was subsequently targeted using a ribozyme transgene system and its role in angiogenesis assessed using in vitro and in vivo assays. The importance of RGMb in pro-angiogenic responses to HGF and BMP-7 was also assessed. Microarray analysis identified RGMb as a gene upregulated as a result of HGF treatment. Knockdown of RGMb, in HECV cells, had minimal effects on tubule formation, brought about a general, although non-significant increase in cell growth and enhanced cell migration. Similarly, no significant effect of RGMb knockdown was found in vivo using a co-inoculation angiogenesis model. Knockdown of RGMb was, however, found to reduce the responsiveness of HECV cells to HGF treatment and particularly to BMP-7 treatment in regard to the enhanced migratory and tubule formation brought about by these treatments in vitro. Our results indicate that RGMb expression can be influenced by HGF treatment. Whilst this molecule appears to have minimal impact on angiogenic traits individually, it demonstrates an involvement in propagating pro-angiogenic effects of HGF and particularly BMP-7 and thus, may play a role in regulating angiogenic responses to HGF and BMP-7.

View Figures

View References

1	Folkman J: Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007. View Article : Google Scholar : PubMed/NCBI
2	Potente M, Gerhardt H and Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell. 146:873–887. 2011. View Article : Google Scholar : PubMed/NCBI
3	Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K and Nakamura T: Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol. 53:35–69. 2005. View Article : Google Scholar : PubMed/NCBI
4	Wojta J, Kaun C, Breuss JM, et al: Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest. 79:427–438. 1999.
5	Davies G, Mason MD, Martin TA, et al: The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. Int J Cancer. 106:348–354. 2003. View Article : Google Scholar : PubMed/NCBI
6	Martin TA, Parr C, Davies G, et al: Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis. 24:1317–1323. 2003. View Article : Google Scholar : PubMed/NCBI
7	Monnier PP, Sierra A, Macchi P, et al: RGM is a repulsive guidance molecule for retinal axons. Nature. 419:392–395. 2002. View Article : Google Scholar : PubMed/NCBI
8	Oldekamp J, Kramer N, Alvarez-Bolado G and Skutella T: Expression pattern of the repulsive guidance molecules RGM A, B and C during mouse development. Gene Expr Patterns. 4:283–288. 2004. View Article : Google Scholar : PubMed/NCBI
9	Schmidtmer J and Engelkamp D: Isolation and expression pattern of three mouse homologues of chick Rgm. Gene Expr Patterns. 4:105–110. 2004. View Article : Google Scholar : PubMed/NCBI
10	Niederkofler V, Salie R, Sigrist M and Arber S: Repulsive guidance molecule (RGM) gene function is required for neural tube closure but not retinal topography in the mouse visual system. J Neurosci. 24:808–818. 2004. View Article : Google Scholar : PubMed/NCBI
11	Samad TA, Srinivasan A, Karchewski LA, et al: DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J Neurosci. 24:2027–2036. 2004. View Article : Google Scholar
12	Ma CH, Brenner GJ, Omura T, et al: The BMP coreceptor RGMb promotes while the endogenous BMP antagonist noggin reduces neurite outgrowth and peripheral nerve regeneration by modulating BMP signaling. J Neurosci. 31:18391–18400. 2011. View Article : Google Scholar : PubMed/NCBI
13	Liu X, Hashimoto M, Horii H, Yamaguchi A, Naito K and Yamashita T: Repulsive guidance molecule b inhibits neurite growth and is increased after spinal cord injury. Biochem Biophys Res Commun. 382:795–800. 2009. View Article : Google Scholar
14	Samad TA, Rebbapragada A, Bell E, et al: DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem. 280:14122–14129. 2005. View Article : Google Scholar : PubMed/NCBI
15	Babitt JL, Zhang Y, Samad TA, et al: Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem. 280:29820–29827. 2005. View Article : Google Scholar : PubMed/NCBI
16	Babitt JL, Huang FW, Wrighting DM, et al: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 38:531–539. 2006. View Article : Google Scholar : PubMed/NCBI
17	Halbrooks PJ, Ding R, Wozney JM and Bain G: Role of RGM coreceptors in bone morphogenetic protein signaling. J Mol Signal. 2:42007. View Article : Google Scholar : PubMed/NCBI
18	Xia Y, Sidis Y, Mukherjee A, et al: Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology. 146:3614–3621. 2005. View Article : Google Scholar : PubMed/NCBI
19	Xia Y, Cortez-Retamozo V, Niederkofler V, et al: Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. J Immunol. 186:1369–1376. 2011. View Article : Google Scholar : PubMed/NCBI
20	Li J, Ye L, Mansel RE and Jiang WG: Potential prognostic value of repulsive guidance molecules in breast cancer. Anticancer Res. 31:1703–1711. 2011.PubMed/NCBI
21	Li J, Ye L, Kynaston HG and Jiang WG: Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells. Int J Oncol. 40:544–550. 2012.PubMed/NCBI
22	Li J, Ye L, Sanders AJ and Jiang WG: Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling. J Cell Biochem. 113:2523–2531. 2012. View Article : Google Scholar : PubMed/NCBI
23	Sanders AJ, Parr C, Mason MD and Jiang WG: Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro. Int J Mol Med. 20:613–619. 2007.
24	Yuan Z, Sanders AJ, Ye L, Wang Y and Jiang WG: Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol Rep. 26:237–245. 2011.PubMed/NCBI
25	Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406–3415. 2003. View Article : Google Scholar : PubMed/NCBI
26	Parr C, Sanders AJ, Davies G, et al: Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin Cancer Res. 13:3568–3576. 2007. View Article : Google Scholar : PubMed/NCBI
27	Parr C, Watkins G, Mansel RE and Jiang WG: The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res. 10:202–211. 2004. View Article : Google Scholar : PubMed/NCBI
28	Jiang WG, Hiscox SE, Parr C, et al: Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res. 5:3695–3703. 1999.
29	Sanders AJ, Ye L, Mason MD and Jiang WG: The impact of EPLINalpha (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis. Angiogenesis. 13:317–326. 2010. View Article : Google Scholar : PubMed/NCBI
30	David L, Feige JJ and Bailly S: Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 20:203–212. 2009. View Article : Google Scholar : PubMed/NCBI
31	Cai J, Pardali E, Sanchez-Duffhues G and ten Dijke P: BMP signaling in vascular diseases. FEBS Lett. 586:1993–2002. 2012. View Article : Google Scholar
32	Ye L, Lewis-Russell JM, Davies G, Sanders AJ, Kynaston H and Jiang WG: Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells. Int J Oncol. 30:521–529. 2007.PubMed/NCBI
33	Ye L, Lewis-Russell JM, Sanders AJ, Kynaston H and Jiang WG: HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. Urol Oncol. 26:190–197. 2008. View Article : Google Scholar : PubMed/NCBI
34	Kanomata K, Kokabu S, Nojima J, Fukuda T and Katagiri T: DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells. 14:695–702. 2009. View Article : Google Scholar : PubMed/NCBI